🔎 Trials Near Me

Hjem › Multippel sklerose › Missouri

Kliniske studier for Multippel sklerose i Missouri

8 studier for Multippel sklerose søker deltakere på steder i Missouri.

Byer i Missouri

Offisiell studietekst (engelsk)

A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

  • Washington University School of Medicine, St Louis
RekruttererFase 2
Alder 18 til 70 · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06782490

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
  • Siteman Cancer Center at West County Hospital, Creve Coeur
  • University Health Truman Medical Center, Kansas City
  • og 6 flere
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 23. sep. 2026 · NCT03816345

Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis

  • Washington University, St. Louis, St Louis
RekruttererFase 1/2
Alder 18 til 65 · Alle kjønn · Oppdatert 21. sep. 2026 · NCT07477639

An Open-label Study of AZD0120 in Adults With Multiple Sclerosis

  • Research Site, St Louis
RekruttererFase 1
Alder 18 til 60 · Alle kjønn · Oppdatert 25. aug. 2026 · NCT07224373

Brain Imaging and Immune Changes During Remibrutinib Treatment in Multiple Sclerosis.

  • Washington University School of Medicine in St. Louis, St Louis
RekruttererObservasjonsstudie
Alder 40 til 70 · Alle kjønn · Oppdatert 11. aug. 2026 · NCT07758270

This Study Involves a Positron Emission Tomography (PET) Scan Using a New Investigational Radioactive Tracer, [18F]-FZTA, to Detect Inflammation in the Brain. The Tracer Will be Tested in Healthy Younger Adults and Individuals With Multiple Sclerosis.

  • Washington University in St. Louis, St Louis
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 18 og eldre · Alle kjønn · Oppdatert 4. aug. 2026 · NCT07115017

A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years

  • Washington University School of Medicine Neurology Clinical Unit, St Louis
RekruttererFase 2
Alder 18 til 55 · Alle kjønn · Oppdatert 15. jun. 2026 · NCT06735248

Smoldering Inflammation in MS

  • Barnes Jewish Center for Clinical Imaging Research, St Louis
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 28. apr. 2026 · NCT06591429

Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.